For following the competition: what moved in each program, several studies read as one move.
- Autologous Anti-CD7 CAR T Cells PA3-17
- LV009
- UTAA91
- + 1 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add PersonGen BioTherapeutics (Suzhou) to watchlistEvery Monday by email · turn it off any timePro · free during the beta